These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. Pathak P, Liu H, Boehme S, Xie C, Krausz KW, Gonzalez F, Chiang JYL. J Biol Chem; 2017 Jun 30; 292(26):11055-11069. PubMed ID: 28478385 [Abstract] [Full Text] [Related]
25. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. Pellicciari R, Sato H, Gioiello A, Costantino G, Macchiarulo A, Sadeghpour BM, Giorgi G, Schoonjans K, Auwerx J. J Med Chem; 2007 Sep 06; 50(18):4265-8. PubMed ID: 17685603 [Abstract] [Full Text] [Related]
27. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Katsuma S, Hirasawa A, Tsujimoto G. Biochem Biophys Res Commun; 2005 Apr 01; 329(1):386-90. PubMed ID: 15721318 [Abstract] [Full Text] [Related]
29. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5. Trammell SAJ, Svenningsen JS, Holst JJ, Gillum MP, Kuhre RE. Molecules; 2020 May 20; 25(10):. PubMed ID: 32443832 [Abstract] [Full Text] [Related]
30. Bile acids alter male fertility through G-protein-coupled bile acid receptor 1 signaling pathways in mice. Baptissart M, Vega A, Martinot E, Pommier AJ, Houten SM, Marceau G, de Haze A, Baron S, Schoonjans K, Lobaccaro JM, Volle DH. Hepatology; 2014 Sep 20; 60(3):1054-65. PubMed ID: 24798773 [Abstract] [Full Text] [Related]
31. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Keitel V, Häussinger D. Clin Res Hepatol Gastroenterol; 2012 Oct 20; 36(5):412-9. PubMed ID: 22521118 [Abstract] [Full Text] [Related]
33. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice. Gillard J, Clerbaux LA, Nachit M, Sempoux C, Staels B, Bindels LB, Tailleux A, Leclercq IA. JHEP Rep; 2022 Jan 20; 4(1):100387. PubMed ID: 34825156 [Abstract] [Full Text] [Related]
34. Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, André P. J Hepatol; 2008 Feb 20; 48(2):192-9. PubMed ID: 18096266 [Abstract] [Full Text] [Related]
35. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Broeders EP, Nascimento EB, Havekes B, Brans B, Roumans KH, Tailleux A, Schaart G, Kouach M, Charton J, Deprez B, Bouvy ND, Mottaghy F, Staels B, van Marken Lichtenbelt WD, Schrauwen P. Cell Metab; 2015 Sep 01; 22(3):418-26. PubMed ID: 26235421 [Abstract] [Full Text] [Related]
36. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y, Adorini L, Lee YK, Kasumov T, Yin L, Zhang Y. Mol Metab; 2018 Mar 01; 9():131-140. PubMed ID: 29361497 [Abstract] [Full Text] [Related]
37. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. J Nutr Biochem; 2006 Sep 01; 17(9):571-88. PubMed ID: 16524713 [Abstract] [Full Text] [Related]
38. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K, Hara S, Kikugawa K, Hayakawa M. FEBS J; 2009 Mar 01; 276(5):1319-32. PubMed ID: 19187229 [Abstract] [Full Text] [Related]
39. Mice lacking the thyroid hormone receptor-alpha gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Endocrinology; 2008 Dec 01; 149(12):6471-86. PubMed ID: 18719022 [Abstract] [Full Text] [Related]
40. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. Wang S, Sheng F, Zou L, Xiao J, Li P. J Adv Res; 2021 Dec 01; 34():109-122. PubMed ID: 35024184 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]